Breaking Boundaries: Nexcella Inc., a Subsidiary of Immix Biopharma, to Showcase at Prestigious European Medical Conference
Breaking Boundaries: Nexcella Inc., a Subsidiary of Immix Biopharma, to Showcase at Prestigious European Medical Conference Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands February 9-11, 2023 LOS ANGELES, CA, Dec. 28, 2022 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…